menu Search
Zuellig Pharma

CELLTRION HEALTHCARE (THAILAND) LTD.

Featured products of Celltrion Healthcare
Herzuma
Herzuma powd for infusion 150 mg
trastuzumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
Herzuma powd for infusion 440 mg
trastuzumab
Packing/Price
((+1 vial 20-mL diluent)) 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
Remsima
Remsima powd for conc for soln for infusion 100 mg
infliximab
Packing/Price
1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AB02 - infliximab : Belongs to the class of tumor necrosis factor alpha (TNF-alpha) inhibitors. Used as immunosuppressants.
Remsima 120 mg
Remsima 120 mg soln for inj 120 mg/mL
infliximab
Packing/Price
1 mL x 1's1 mL x 2 × 1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AB02 - infliximab : Belongs to the class of tumor necrosis factor alpha (TNF-alpha) inhibitors. Used as immunosuppressants.
Truxima
Truxima conc for soln for infusion 10 mg/mL
rituximab
Packing/Price
10 mL x 2 × 1's50 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FA01 - rituximab : Belongs to the class of CD20 (Clusters of Differentiation 20) inhibitors. Used in the treatment of cancer.
/thailand/image/info/truxima-conc-for-soln-for-infusion-10-mg-ml/100-mg-10-ml?id=2a0bb425-c9bc-4e33-916b-ac07010aaab7
/thailand/image/info/truxima-conc-for-soln-for-infusion-10-mg-ml/500-mg-50-ml?id=63f37d04-4101-4b08-9673-ac07010aaab7
Yuflyma
Yuflyma soln for inj 40 mg/0.4 mL
adalimumab
Packing/Price
1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AB04 - adalimumab : Belongs to the class of tumor necrosis factor alpha (TNF-alpha) inhibitors. Used as immunosuppressants.
Distributed by Zuellig Pharma
Herzuma
Herzuma powd for infusion 150 mg
trastuzumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
Herzuma powd for infusion 440 mg
trastuzumab
Packing/Price
((+1 vial 20-mL diluent)) 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
Remsima
Remsima powd for conc for soln for infusion 100 mg
infliximab
Packing/Price
1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AB02 - infliximab : Belongs to the class of tumor necrosis factor alpha (TNF-alpha) inhibitors. Used as immunosuppressants.
Remsima 120 mg
Remsima 120 mg soln for inj 120 mg/mL
infliximab
Packing/Price
1 mL x 1's1 mL x 2 × 1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AB02 - infliximab : Belongs to the class of tumor necrosis factor alpha (TNF-alpha) inhibitors. Used as immunosuppressants.
Truxima
Truxima conc for soln for infusion 10 mg/mL
rituximab
Packing/Price
10 mL x 2 × 1's50 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FA01 - rituximab : Belongs to the class of CD20 (Clusters of Differentiation 20) inhibitors. Used in the treatment of cancer.
/thailand/image/info/truxima-conc-for-soln-for-infusion-10-mg-ml/100-mg-10-ml?id=2a0bb425-c9bc-4e33-916b-ac07010aaab7
/thailand/image/info/truxima-conc-for-soln-for-infusion-10-mg-ml/500-mg-50-ml?id=63f37d04-4101-4b08-9673-ac07010aaab7
Yuflyma
Yuflyma soln for inj 40 mg/0.4 mL
adalimumab
Packing/Price
1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AB04 - adalimumab : Belongs to the class of tumor necrosis factor alpha (TNF-alpha) inhibitors. Used as immunosuppressants.